Growth inhibition of pancreatic cancer by targeted delivery of gemcitabine via fucoidan-coated pH-sensitive liposomes
- 5 August 2024
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 277 (Pt 3) , 134517
Abstract
No abstract availableKeywords
Funding Information
- Priority Academic Program Development of Jiangsu Higher Education Institutions
This publication has 44 references indexed in Scilit:
- Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancerEuropean Journal of Pharmaceutics and Biopharmaceutics, 2023
- Real‐Time Objective Evaluation of the Ischemic Stroke through pH‐Responsive Fluorescence ImagingAdvanced Healthcare Materials, 2023
- Biomimetic Liposomal Nanoplatinum for Targeted Cancer ChemophototherapyAdvanced Science, 2021
- The Extracellular Matrix Modulates the Metastatic JourneyDevelopmental Cell, 2019
- Nanoscale platforms for messenger RNA deliveryWIREs Nanomedicine and Nanobiotechnology, 2018
- Recurrence after resection for ductal adenocarcinoma of the pancreasWorld Journal of Surgery, 1997
- Liposomes obtained by the ethanol injection methodInternational Journal of Pharmaceutics, 1993
- pH in the endosomeExperimental Cell Research, 1984
- Induced drug release from lipid vesicles in serum by pH-changeEuropean Biophysics Journal, 1980
- Studies on membrane fusion. II. Induction of fusion in pure phospholipid membranes by calcium ions and other divalent metalsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976